Characteristic | RIC (N = 37) | Sham-RIC (N = 40) | p value | |
---|---|---|---|---|
Age—yr | 74.97 ± 11.55 | 74.75 ± 11.58 | 0.933 | |
Male sex—no. (%) | 23 (62.2%) | 24 (60.0%) | 0.846 | |
Admission SBP, mmHg | 130.49 ± 27.93 | 130.40 ± 25.68 | 0.989 | |
Admission DBP, mmHg | 74.16 ± 15.54 | 71.80 ± 16.13 | 0.515 | |
Serum glucose, mmol/L | 7.48 ± 2.78 | 8.50 ± 4.44 | 0.233 | |
LDL, mmol/L | 2.36 ± 0.86 | 2.43 ± 1.13 | 0.738 | |
hs-CRP, mg/L | 16.20 (8.21–30.50) | 30.50 (5.95–40.54) | 0.230 | |
Vascular risk factor | ||||
Hypertension, n (%) | 30 (81.1%) | 25 (62.5%) | 0.071 | |
Diabetes, n (%) | 13 (35.1%) | 15 (37.5%) | 0.829 | |
Hyperlipidemia, n (%) | 9 (24.3%) | 12 (30.0%) | 0.576 | |
Arrhythmia, n (%) | 13 (35.1%) | 16 (40%) | 0.660 | |
Atrial fibrillation, n (%) | 7 (18.9%) | 10 (25%) | 0.520 | |
Smoke, n (%) | 10 (27.0%) | 15 (37.5%) | 0.327 | |
Alcohol, n (%) | 4 (10.8%) | 6 (15%) | 0.585 | |
History of prior coronary heart disease, n (%) | 20 (54.1%) | 17 (42.5%) | 0.311 | |
Prior ischemic stroke, n (%) | 15 (40.5%) | 19 (47.5%) | 0.539 | |
Pre-stroke antithrombotic therapy | ||||
None, n (%) | 9 (24.3%) | 11 (27.5%) | 0.751 | |
Single antiplatelet, n (%) | 25 (67.6%) | 29 (72.5%) | 0.637 | |
Dual antiplatelet, n (%) | 3 (8.1%) | 0 (0.0%) | 0.106 | |
Location of AIS | 0.818 | |||
Anterior circulation, n (%) | 25 (67.6%) | 28 (70.0%) | ||
Posterior circulation, n (%) | 12 (32.4%) | 12 (30.0%) | ||
Stroke etiology* | 0.884 | |||
Large-artery atherosclerosis, n (%) | 24 (64.9%) | 26 (65.0%) | ||
Cardioembolism, n (%) | 5 (13.5%) | 6 (15.0%) | ||
Small-vessel occlusion, n (%) | 5 (13.5%) | 4 (10.0%) | ||
Stroke of other determined etiology, n (%) | 0 (0%) | 1 (2.5%) | ||
Stroke of undetermined etiology, n (%) | 3 (8.1%) | 3 (7.5%) | ||
Intracranial artery stenosis, n (%)^ | 18 (48.7%) | 18 (45%) | 0.749 | |
Acute coronary syndrome type | 0.642 | |||
STEMI, n (%) | 6 (16.2%) | 5 (12.5%) | ||
NSTEMI, n (%) | 31 (83.8%) | 35 (87.5%) | ||
Severity of AMI | ||||
GRACE score | 177.0 (160.0–194.5) | 190.5 (163.3–206.5) | 0.155 | |
Severity of stroke | ||||
NHISS score | 8 (4–12) | 6.25 (4.25–14) | 0.810 | |
mRS score | 4 (3.5–5) | 4 (4–4) | 0.787 | |
LVEF, % | 63.0 (49.0–67.0) | 57.1 (51.0–66.0) | 0.588 | |
Stroke onset to enrollment, h | 17.00 (13.00–20.00) | 19.75 (12.00–22.38) | 0.232 | |
Stroke onset to RIC treatment, h | 18.00 (14.00–21.50) | 21.00 (13.50–23.60) | 0.245 |